These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26097434)

  • 1. Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components.
    Stafylas P; Kourlaba G; Hatzikou M; Georgiopoulos D; Sarafidis P; Maniadakis N
    Cost Eff Resour Alloc; 2015; 13():10. PubMed ID: 26097434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of antihypertensive triple combination therapy among patients enrolled in a Medicare advantage plan.
    Wang X; Chen H; E E; Wu J; Serna O; Paranjpe R; Abughosh S
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):829-836. PubMed ID: 32703040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost Effectiveness of the First-in-Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting.
    Dong X; He X; Wu J
    Pharmacoeconomics; 2022 Dec; 40(12):1187-1205. PubMed ID: 36071264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan.
    Chan L; Chen CH; Hwang JJ; Yeh SJ; Shyu KG; Lin RT; Li YH; Liu LZ; Li JZ; Shau WY; Weng TC
    Int J Gen Med; 2016; 9():175-82. PubMed ID: 27330323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial.
    Lung T; Jan S; de Silva HA; Guggilla R; Maulik PK; Naik N; Patel A; de Silva AP; Rajapakse S; Ranasinghe G; Prabhakaran D; Rodgers A; Salam A; Selak V; Stepien S; Thom S; Webster R; Lea-Laba T;
    Lancet Glob Health; 2019 Oct; 7(10):e1359-e1366. PubMed ID: 31477545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden.
    Ekman M; Bienfait-Beuzon C; Jackson J
    J Hum Hypertens; 2008 Dec; 22(12):845-55. PubMed ID: 18633426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
    Xie L; Frech-Tamas F; Marrett E; Baser O
    Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma.
    Fust K; Li X; Maschio M; Villa G; Parthan A; Barron R; Weinstein MC; Somers L; Hoefkens C; Lyman GH
    Pharmacoeconomics; 2017 Apr; 35(4):425-438. PubMed ID: 27928760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
    Huan Y; Townsend R
    Expert Opin Pharmacother; 2012 Nov; 13(16):2409-15. PubMed ID: 23067322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA; Lacourcière Y; Chiang YT; Glazer RD
    Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis.
    Kourlaba G; Fragoulakis V; Maniadakis N
    Appl Health Econ Health Policy; 2012 Jul; 10(4):261-71. PubMed ID: 22667992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients].
    Buti M; Gros B; Oyagüez I; Andrade RJ; Serra MA; Turnes J; Casado MA
    Farm Hosp; 2014 Sep; 38(5):418-29. PubMed ID: 25344136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medication of the month. Exforge HCT: combination of amlodipine besylate, valsartan and hydrochlorothiazide in a single tablet].
    Lancellotti P
    Rev Med Liege; 2010; 65(7-8):471-5. PubMed ID: 20857707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cost-Effectiveness Analysis between Amlodipine and Angiotensin II Receptor Blockers in Stroke and Myocardial Infarction Prevention among Hypertension Patients in China.
    Wu Y; Zhou Q; Xuan J; Li M; Zelt S; Huang Y; Yin H; Huang M
    Value Health Reg Issues; 2013 May; 2(1):75-80. PubMed ID: 29702856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G; Ong SH; Chen W; Wei ZJ; Kahler KH
    Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-combination therapy in the treatment of hypertension: a review of the evidence.
    Düsing R; Waeber B; Destro M; Santos Maia C; Brunel P
    J Hum Hypertens; 2017 Aug; 31(8):501-510. PubMed ID: 28230062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.